DCIS (Ductal Carcinoma in Situ) News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Go Low With Tamoxifen for DCIS Go Low With Tamoxifen for DCIS
In a potentially practice-changing result, use of a 5-mg daily dose of tamoxifen for patients with ductal carcinoma in situ (DCIS) prevented new and recurrent breast cancer events in comparison with placebo.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Low-dose tamoxifen reduced recurrence and new disease for patients with DCIS, LCIS, and ADH
(American Association for Cancer Research) Treatment with a low dose of tamoxifen (5 mg per day) halved the risk of disease recurrence and new disease for women who had been treated with surgery following a diagnosis of breast intraepithelial neoplasia compared with placebo, and it did not cause more serious adverse events, according to data from the randomized, phase III TAM-01 clinical trial presented at the 2018 San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news
Radiation therapy cuts low risk of recurrence by nearly 3/4 for patients with 'good risk'
(American Society for Radiation Oncology) A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2018 Category: Cancer & Oncology Source Type: news
ASTRO: SABR is effective for oligometastatic cancers
Stereotactic ablative radiotherapy (SABR) can greatly increase how long oligometastatic...Read more on AuntMinnie.comRelated Reading:
ASTRO: Weekly breast radiation therapy is safe
ASTRO: AI's rad therapy future is in predicting outcomes
Study gives all-clear for skin cream during radiation therapy
PET/CT predicts success of rad therapy for spinal mets
Is radiation therapy warranted for DCIS postlumpectomy? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 23, 2018 Category: Radiology Source Type: news
Radiation Therapy Cuts Recurrence in'Good Risk' DCIS Radiation Therapy Cuts Recurrence in'Good Risk' DCIS
Whole-breast radiation halved the risk for recurrence in low-risk ductal carcinoma in situ (DCIS), but treatment after surgery needs to part of a physician-patient discussion.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
RT Add-On Boosts Outcomes in'Low-Risk' DCIS Breast Ca
(MedPage Today) -- Highest benefit seen in patients who also used tamoxifen (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 22, 2018 Category: Hematology Source Type: news
ASTRO: Radiation therapy slashes breast cancer recurrence
Whole-breast radiation therapy can significantly lower the risk of recurrent...Read more on AuntMinnie.comRelated Reading:
Can dedicated breast PET identify suspicious lesions?
Women still need breast imaging after mastectomy
Is radiation therapy warranted for DCIS postlumpectomy?
Microbubbles improve breast cancer radiation therapy
ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2018 Category: Radiology Source Type: news
ASTRO: Weekly breast radiation therapy is safe
A larger, weekly dose of radiation therapy has side effects that are comparable...Read more on AuntMinnie.comRelated Reading:
Can dedicated breast PET identify suspicious lesions?
Women still need breast imaging after mastectomy
Is radiation therapy warranted for DCIS postlumpectomy?
Microbubbles improve breast cancer radiation therapy
ASTRO: Short radiation course safe for breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2018 Category: Radiology Source Type: news
Women still need breast imaging after mastectomy
Although women may be increasingly choosing mastectomy as a breast cancer treatment,...Read more on AuntMinnie.comRelated Reading:
Fewer high-risk women get mammography after USPSTF change
Is radiation therapy warranted for DCIS postlumpectomy?
Breast cancer follow-up imaging varies widely
Biopsy rate is low after breast cancer
What's the best way to follow up breast cancer survivors? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 9, 2018 Category: Radiology Source Type: news
Mastectomy Not the Only Option in Extensive DCIS
(MedPage Today) -- Lumpectomy plus RT viable if risks, benefits are explained (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - September 28, 2018 Category: OBGYN Source Type: news
Lumpectomy + Radiation May Cut Breast Cancer Mortality in DCIS
Lumpectomy, radiotherapy tied to reduction in breast cancer mortality versus lumpectomy, mastectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 20, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Surgery, Journal, Source Type: news
Lumpectomy & #43; Radiation May Cut Breast Cancer Mortality in DCIS
MONDAY, Aug. 20, 2018 -- Treatment with lumpectomy and radiotherapy is associated with a reduction in breast cancer mortality versus lumpectomy or mastectomy alone among patients with ductal carcinoma in situ (DCIS), according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 20, 2018 Category: Pharmaceuticals Source Type: news
Is radiation therapy warranted for DCIS postlumpectomy?
Researchers have found that radiation therapy after lumpectomy in women with...Read more on AuntMinnie.comRelated Reading:
Microbubbles improve breast cancer radiation therapy
ASTRO: Short radiation course safe for breast cancer
LED device could predict skin damage from breast RT
Robotic IMRT-APBI works well for breast cancer patients
SABCS: Study links APBI to higher complication rates (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news
Lumpectomy Plus RT Tied to Lower Mortality in DCIS Lumpectomy Plus RT Tied to Lower Mortality in DCIS
Lumpectomy plus radiation is associated with a small but statistically significant reduced risk for breast cancer-related death compared to the other major options for ductal carcinoma in situ (DCIS).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Association of radiation therapy plus lumpectomy in reduced risk of dying in women with DCIS
(JAMA Network) Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma in situ (DCIS), a noninvasive early form of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 10, 2018 Category: Cancer & Oncology Source Type: news
ASBrS: Regular mammo screening = less-invasive treatment
Regular breast cancer screening, particularly in younger women, translates...Read more on AuntMinnie.comRelated Reading:
ASBrS: No, we're not overtreating DCIS
ASBrS: 50% of women under 45 at elevated breast cancer risk
ASBrS: For node-positive breast cancer, radiotherapy is best
ASBrS: Radiotherapy after mastectomy may not be beneficial
ASBrS: RF ablation shows promise; thermography not so much (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news
Does double reading improve breast cancer screening?
Conclusions? 1) My conclusion is that this proves that double reading adds nothing important to screening - particularly if women are getting yearly mammograms. This should be the stake in the heart of the double reading vampire. Given the criticism of mammography - that it doesn't save many, or any lives, this extra tenth of a percent of diagnosis is even more questionable. Nah, not just questionable, I'd say it is so low that there are probably, within error bars, no lives saved. Do they say this. No: "Detecting these extra cancers may be associated with detecting important patho...
Source: AuntMinnie.com Headlines - April 19, 2018 Category: Radiology Source Type: news
Women With DCIS Who Are at Low Risk for Recurrence Identified Women With DCIS Who Are at Low Risk for Recurrence Identified
Women with ductal carcinoma in situ (DCIS) who are at low risk for disease recurrence after conservative breast surgery and radiotherapy, and whose treatment could be reduced, have been identified.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling
At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Patrick I. Borgen, MD Tags: Breast Cancer Conference Report Conferences/MBCC Source Type: news
Women with DCIS at lowest risk of recurrence if they are post-menopausal or ER+
(ECCO-the European CanCer Organisation) Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news
Cancer: Breast radiation therapy isn't so bad
Women with breast cancer who undergo radiation therapy may have fears about...Read more on AuntMinnie.comRelated Reading:
Biopsy rate is low after breast cancer
ASTRO: Breast radiation 'less scary' than expected
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy
Accelerated RT with boost works well for breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 1, 2018 Category: Radiology Source Type: news
High Detection Rates of High - Grade DCIS Persist
Low - , intermediate - grade DCIS less frequently ID'd in subsequent screening rounds vs. prevalence round (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 7, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Radiology, Journal, Source Type: news
Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial
This research article has led to a Practice Changing Update in DynaMed Plus. It concludes that radioactive seed localization may have similar positive margin but higher successful placement rates compared to wire localization in women having breast-conserving surgery for nonpalpable invasive breast cancer or ductal carcinoma in situ (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 18, 2018 Category: Consumer Health News Source Type: news
' Cultural Change' in DCIS'Cultural Change' in DCIS
Some think it's time to change how we talk about DCIS and to consider de-escalation of therapy. Drs Kathy Miller and Shelley Hwang discuss these hot topics and the COMET study at SABCS 2017.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 17, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
New Analytical Tool May Determine How DCIS Invasion Occurs
A new analytical tool called topographic single-cell sequencing can reveal a direct genomic lineage between in situ and invasive tumor subpopulations, which may help decipher how and why some DCIS become invasive. (Source: CancerNetwork)
Source: CancerNetwork - January 16, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Breast Cancer News Source Type: news
New cancer model shows genomic link between early-stage and invasive breast cancer types
(University of Texas M. D. Anderson Cancer Center) A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 4, 2018 Category: Biology Source Type: news
Women not getting recommended breast radiation therapy
Almost 10% of women don't receive radiation therapy after breast conservation...Read more on AuntMinnie.comRelated Reading:
ASTRO: Breast radiation 'less scary' than expected
JCO releases new sentinel node biopsy guidelines
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2017 Category: Radiology Source Type: news
Local DCIS Recurrence After Skipping Adjuvant Radiation Local DCIS Recurrence After Skipping Adjuvant Radiation
Omitting radiation after lumpectomy for pure ductal carcinoma in situ (DCIS) does not improve the chance of breast preservation in case of local recurrence, researchers from Canada have observed.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 6, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news
COUNTERPOINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?
To universally recommend breast irradiation for all women after excision of DCIS lesions ignores information now available to us that can spare the majority of women with DCIS the downsides of RT, but be applied in the treatment of DCIS patients at greater risk for invasive disease. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2017 Category: Cancer & Oncology Authors: William C. Wood, MD Tags: Breast Cancer Oncology Journal Source Type: news
POINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?
At this time RT following BCS remains the standard of care for most patients. Current tools, including prognostic scores and tumor genetics, have failed to identify a cohort for whom RT confers no benefit with respect to invasive recurrences. (Source: CancerNetwork)
Source: CancerNetwork - August 15, 2017 Category: Cancer & Oncology Authors: Camille Berriochoa, MD Carisa Bohnak, BS Chirag Shah, MD Nicole Chahine, BS Tags: Breast Cancer Oncology Journal Source Type: news
Benefit of Radiotherapy After Breast Conservation in DCIS Benefit of Radiotherapy After Breast Conservation in DCIS
Can this molecular assay help determine who will benefit from radiotherapy after breast-conserving therapy for DCIS?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Don ’t Be Fooled by DCIS
A 46-year-old woman had a routine screening mammogram that showed new calcifications in the posterior left breast. A diagnostic mammogram showed several small punctate calcifications, and a 6-month interval follow-up was recommended. (Source: CancerNetwork)
Source: CancerNetwork - July 15, 2017 Category: Cancer & Oncology Authors: Colleen D. Murphy, MD Dulcy E. Wolverton, MD Rachel A. Rabinovitch, MD Regina J. Brown, MD Sharon Sams, MD, MPH Tae Chong, MD Virginia F. Borges, MD, MMSc Tags: Breast Cancer Case Studies Oncology Journal Source Type: news
Photoacoustic imaging could guide breast cancer removal
A new technique based on photoacoustic imaging could help surgeons determine...Read more on AuntMinnie.comRelated Reading:
Contrast US helps assess breast cancer treatment response
Bilateral mastectomy not needed for DCIS
DBT reduces breast surgery re-excision rates
Supine MRI in the OR can improve breast surgery outcome
Lumpectomy with RT tops mastectomy for early-stage cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 17, 2017 Category: Radiology Source Type: news
' Unique' DCIS Study: Double Mastectomy Not Needed'Unique' DCIS Study: Double Mastectomy Not Needed
Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 2, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Triple-modality therapy foils rare breast cancer
Traditional triple-modality therapy for breast cancer also works for a rare...Read more on AuntMinnie.comRelated Reading:
ASTRO: Radiation boost cuts local recurrence in DCIS patients
Choosing Wisely boosts use of short-course breast radiation therapy
Accelerated RT with boost works well for breast cancer patients
Bras aid positioning for large-breasted women during RT
ASCO BSC: Long-term APBI outcomes are favorable (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 28, 2017 Category: Radiology Source Type: news
Bilateral mastectomy not needed for DCIS
Women with ductal carcinoma in situ (DCIS) who choose bilateral mastectomy...Read more on AuntMinnie.comRelated Reading:
How accurate are DCIS predictions from radiologists?
Overdiagnosis claims not supported, ACR, SBI say
ASTRO: Radiation boost cuts local recurrence in DCIS patients
New treatment guidelines issued for DCIS
Needle biopsy hormone testing unnecessary for DCIS (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 28, 2017 Category: Radiology Source Type: news
Bilateral Mastectomy in DCIS May Be Overtreatment
Women who undergo bilateral mastectomy for the treatment of DCIS may be overtreated, according to the results of a new study. (Source: CancerNetwork)
Source: CancerNetwork - April 27, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Breast Cancer News Source Type: news
How accurate are DCIS predictions from radiologists?
Radiologists can predict the presence of invasive cancer with fairly high accuracy,...Read more on AuntMinnie.comRelated Reading:
Mammography recall rates: Is lower really always better?
Cochrane group again takes aim at breast screening
Does screening DBT increase short-term follow-up rates?
Risk-based mammo screening misses almost 60% of cancersComments:
3/30/2017 4:18:32 AMDr.Sardonicus
Amazing that these people got a paper in AJR saying, essentially, that radiologists are unable to read detailed histology from mammograms with perfect accuracy. Did anyone ever think differently? There is a reason...
Source: AuntMinnie.com Headlines - March 30, 2017 Category: Radiology Source Type: news
ASTRO partners with ASCO's CancerLinQ
The American Society for Radiation Oncology (ASTRO) announced that it plans...Read more on AuntMinnie.comRelated Reading:
ASTRO updates guidelines on painful bone metastases
Elekta to support ASTRO safety initiative
ASTRO releases updated APBI guide
ASTRO: Radiation boost cuts local recurrence in DCIS patients
ASCO debuts database of 100K patient records (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 22, 2017 Category: Radiology Source Type: news
Mayo Clinic tests vaccine to provide immune response against early breast lesion
(Mayo Clinic) Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional therapy of surgery and possibly hormonal therapy and radiation. Now, Mayo Clinic researchers are about to test a vaccine that they hope will replace standard therapies and prevent recurrence for some, if not all, these patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2017 Category: Global & Universal Source Type: news
Mayo Clinic to test vaccine designed to provide immune response against early breast lesions
JACKSONVILLE, Fla. ? Only about 35 percent of precancerous breast lesions morph into cancer if untreated, but physicians cannot identify which lesions are potentially dangerous. So all women diagnosed with ductal carcinoma in situ undergo traditional therapy of surgery and possibly hormonal therapy and radiation. Now, Mayo Clinic researchers are about to test a vaccine [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - January 31, 2017 Category: Hospital Management Source Type: news
New Research Shows Breast Cancer Precursor Treatment Causes Women to Live Longer
This study is particularly important because DCIS treatment includes radiotherapy, which can cause damage to nearby organs
More and more people are becoming aware they have DCIS because it is something that shows up in breast cancer screenings—so more women are able to get treated if they have this form of cancer.
For more information on the study, please visit “Women treated for precursor of breast cancer can expect to live as long as other women.”
Follow NN/LM SCR on Twitter and like us on Facebook. (Source: Network News)
Source: Network News - January 31, 2017 Category: Databases & Libraries Authors: NN/LM South Central Region Tags: Consumer Health General (all entries) Patient Safety Public Health Research Source Type: news
Women with DCIS Breast Ca Don't See Greater Death Risk
(MedPage Today) -- And other reports from the European Cancer Congress (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - January 31, 2017 Category: Journals (General) Source Type: news
Women With DCIS Live Longer Than General Population Women With DCIS Live Longer Than General Population
The clinical trial was halted after two patients died, but the deaths were related to the use of fludarabine in the preconditioning regimen.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 30, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Medical News Today: Women with noninvasive breast cancer live as long as other women
Women diagnosed with ductal carcinoma in situ have a slightly higher risk of dying from breast cancer, but a significantly lower all-mortality risk. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 30, 2017 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Women treated for early signs of breast cancer live LONGER
Women over the age of 50 with ductal carcinoma in situ - a precursor of breast cancer - were 10 per cent more likely to be alive ten years after their diagnosis than health women, Dutch researchers found. (Source: the Mail online | Health)
Source: the Mail online | Health - January 28, 2017 Category: Consumer Health News Source Type: news
Good News for Older Women With Early Form of Breast Cancer
A diagnosis of DCIS doesn't lower life expectancy in patients over 50, study finds (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - January 28, 2017 Category: Cancer & Oncology Source Type: news
Good news for older women with early form of breast cancer
A new study offers some reassuring statistics about DCIS, a very early form of breast cancer (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 27, 2017 Category: Consumer Health News Source Type: news
Good News for Older Women With Early Breast Cancer
A diagnosis of DCIS doesn't lower life expectancy in patients over 50, study finds (Source: WebMD Health)
Source: WebMD Health - January 27, 2017 Category: Consumer Health News Source Type: news
Good News for Older Women with Early Form of Breast Cancer
A diagnosis of DCIS doesn't lower life expectancy in patients over 50, study finds
Source: HealthDay
Related MedlinePlus Page: Breast Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 27, 2017 Category: Consumer Health News Source Type: news
